US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist
  • 330.050
  • -1.570-0.47%
Close Dec 13 16:00 ET
  • 330.050
  • 0.0000.00%
Post 20:01 ET
23.90BMarket Cap48.97P/E (TTM)

West Pharmaceutical Services Key Stats

West Pharmaceutical Services Q3 2024 Earnings Date

Currency:USDOct 24, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
709.61M
746.90M
+37.29M
Beat Est.
-5.06%
-0.07%
+5.26%
EPS
1.46
1.85
+0.39
Beat Est.
-31.89%
-13.55%
+26.92%
Strong Buy

Dec 14, 2024

West Pharmaceutical Services Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 732.298M--
--2024/Q4-- / 744.263M--
Oct 24, 20242024/Q3746.900M / 709.606M--
Jul 25, 20242024/Q2702.100M / 728.665M--
Apr 25, 20242024/Q1695.400M / 671.657M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 732.298M--
--2024/Q4-- / 744.263M--
Oct 24, 20242024/Q3746.900M / 709.606M--
Jul 25, 20242024/Q2702.100M / 728.665M--
Apr 25, 20242024/Q1695.400M / 671.657M--

Unlock Free Earnings Estimates

West Pharmaceutical Services Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 14, 2024

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

No Data